Carol Magee
Family Medicine · Anderson, INNPI 1326061631
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 109 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,217 and has fallen 98.8% since, to $14 in 2022.
Across 109 payments — averaging $12.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$239
- Novo Nordisk$207
- AstraZeneca$176
- GSK$175
- Johnson & Johnson$165
- Boehringer Ingelheim$83
- plus $369 from 16 others
What the payments were for
- Food & beverage$1,408100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 22 | $239 |
| Novo Nordisk | 17 | $207 |
| AstraZeneca | 7 | $176 |
| GSK | 22 | $175 |
| Johnson & Johnson | 15 | $165 |
| Boehringer Ingelheim | 5 | $83 |
| TEI Medical Inc. | 1 | $47 |
| Amgen | 2 | $45 |
| Astellas Pharma US Inc | 2 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| Merck | 2 | $28 |
| Pfizer | 2 | $25 |
| AbbVie | 1 | $25 |
| Novartis | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Medtronic | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $14 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
| Corcept Therapeutics | 1 | $13 |
| Genentech USA, Inc. | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
How this compares
$1,414 in reported general payments places this provider in the 65th percentile of 2,709 family medicine providers in Indiana.
Other family medicine in Anderson
- Sam ShaverAnderson$23K
- Charles WilliamsAnderson$16K
- Richard TannerIndianapolis$1.6M
- James AndryBloomington$715K
- Richard FeldmanIndianapolis$476K
- Anthony InzerelloEvansville$308K
- Joe BanksIndianapolis$294K
- Steven GatewoodElwood$281K
- Shekar PushpalaCarmel$239K
- Victoria MoyerKokomo$188K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.